(SOURCE: COLUMBIA UNIVERSITY MEDICAL CENTER) – Precision medicine-based therapy may apply to a wider range of epilepsies. An international study led by Columbia University Medical Center (CUMC) and NewYork-Presbyterian has found that several genes previously implicated only in rare, severe forms of pediatric epilepsy also contribute to common forms of the disorder. “Our findings raise hopes that […]
(Source: McGill University) – Epileptic encephalopathy linked to protein trafficking gene. Researchers have linked a debilitating neurological disease in children to mutations in a gene that regulates neuronal development through control of protein movement within neuronal cells. The scientists from the Montreal Neurological Institute and Hospital at McGill University, led by Peter McPherson, along with collaborators in Saudi […]
(UNIVERSITY OF LIVERPOOL) According to a recent press release, new research from the University of Liverpool, published in the journal Brain, has highlighted the potential reasons why many patients with severe epilepsy still continue to experience seizures even after surgery.
(AMERICAN ACADEMY OF NEUROLOGY) According to a recent press release, a new study shows a link between mothers with rheumatoid arthritis and children with epilepsy. The study is published in the November 16, 2016, online issue of Neurology®, a medical journal of the American Academy of Neurology. Rheumatoid arthritis (RA) is an autoimmune disease that causes […]
(EMORY HEALTH SCIENCES) According to a recent press release, the compound huperzine A can increase resistance to induced seizures in mouse models of genetic epilepsy, scientists at Emory University School of Medicine have found. In particular, huperzine A shows potential for protecting against febrile seizures, which are a feature of both Dravet syndrome, a severe […]
(Epilepsy News Today) According to a recent article published in Epilepsy News Today, the behavior of children with epilepsy predicts those who are at higher risk to develop multiple and severe psychiatric conditions, according to an analysis of information gathered from their parents.
(PRNewswire) Biscayne Pharmaceuticals, Inc., today reported that a new scientific publication shows that lead compound BIS-001 can eliminate all seizures in the majority of animals in models of the catastrophic type of epilepsy known as Dravet syndrome. BIS-001 is a clinical-stage, highly potent agent with a novel mechanism of action that is a synthetic form of […]